VANI

SEC source: 0001753926-25-000831 · form4.xml · derivative · entry 2

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

SEC source: 0001753926-25-000831 · form4.xml · derivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2035-05-11

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001753926-25-000828 · form4.xml · derivative · entry 2

Makes Brigid · CIK 0001375927 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

SEC source: 0001753926-25-000828 · form4.xml · derivative · entry 1

Makes Brigid · CIK 0001375927 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2035-05-11

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001753926-25-000826 · form4.xml · derivative · entry 2

Le Truc · CIK 0001940176 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

SEC source: 0001753926-25-000826 · form4.xml · derivative · entry 1

Le Truc · CIK 0001940176 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2035-05-11

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001753926-25-000824 · form4.xml · derivative · entry 2

Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

SEC source: 0001753926-25-000824 · form4.xml · derivative · entry 1

Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-05-11

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001554855-25-000391 · form4.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 13,828,155

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

F2 · ownership.nature: In addition to the shares the reporting person purchased directly in his name on the open market and in the private sale transaction, the reporting person owns 13,828,155 shares indirectly as follows: (i) 11,702,403 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

SEC source: 0001753926-25-000675 · primary_doc.xml · nonDerivative · entry 2

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 13,827,042

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

F2 · ownership.nature: In addition to the shares the reporting person purchased directly in his name on the open market and in the private sale transaction, the reporting person owns 13,825,230 shares indirectly as follows: (i) 11,701,290 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

SEC source: 0001753926-25-000675 · primary_doc.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 13,826,799

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

F2 · ownership.nature: In addition to the shares the reporting person purchased directly in his name on the open market and in the private sale transaction, the reporting person owns 13,825,230 shares indirectly as follows: (i) 11,701,290 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

SEC source: 0001753926-25-000620 · primary_doc.xml · nonDerivative · entry 2

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 13,825,230

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

F2 · ownership.nature: In addition to the shares the reporting person purchased directly in his name on the open market and in the private sale transaction, the reporting person owns 13,825,230 shares indirectly as follows: (i) 11,699,478 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

SEC source: 0001753926-25-000620 · primary_doc.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 13,822,919

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

F2 · ownership.nature: In addition to the shares the reporting person purchased directly in his name on the open market and in the private sale transaction, the reporting person owns 13,825,230 shares indirectly as follows: (i) 11,699,478 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

SEC source: 0001753926-25-000596 · primary_doc.xml · nonDerivative · entry 5

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 13,804,390

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

F2 · ownership.nature: In addition to the shares the reporting person purchased directly in his name on the open market and in the private sale transaction, the reporting person owns 13,804,390 shares indirectly as follows: (i) 11,678,638 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

SEC source: 0001753926-25-000596 · primary_doc.xml · nonDerivative · entry 4

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 13,741,491

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

F2 · ownership.nature: In addition to the shares the reporting person purchased directly in his name on the open market and in the private sale transaction, the reporting person owns 13,804,390 shares indirectly as follows: (i) 11,678,638 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

SEC source: 0001753926-25-000596 · primary_doc.xml · nonDerivative · entry 2

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,799,200

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

SEC source: 0001753926-25-000596 · primary_doc.xml · nonDerivative · entry 3

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 13,682,908

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

F2 · ownership.nature: In addition to the shares the reporting person purchased directly in his name on the open market and in the private sale transaction, the reporting person owns 13,804,390 shares indirectly as follows: (i) 11,678,638 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

SEC source: 0001753926-25-000596 · primary_doc.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,754,800

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

SEC source: 0001753926-25-000583 · primary_doc.xml · nonDerivative · entry 2

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,720,800

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

SEC source: 0001753926-25-000583 · primary_doc.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,697,861

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

SEC source: 0001753926-25-000555 · primary_doc.xml · nonDerivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

F1 · kind: Individual purchased shares on the open market.

SEC source: 0001753926-25-000392 · primary_doc.xml · nonDerivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,000

F1 · kind: Individual purchased shares on the open market.

SEC source: 0001753926-25-000017 · primary_doc.xml · derivative · entry 1

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,059

Underlying: Common Stock · 50,059 shares

Expires 2034-12-31

F2 · price: Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of cash retainer fees of $45,000.

F1 · derivative.exercise_date: The stock options have a 10-year term and vests quarterly through December 31, 2025, subject to continued service through each such date

F2 · balance_after: Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of cash retainer fees of $45,000.

SEC source: 0001753926-25-000016 · primary_doc.xml · derivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,757

Underlying: Common Stock · 76,757 shares

Expires 2034-12-31

F2 · price: Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of cash retainer fees of $69,000.

F1 · derivative.exercise_date: The stock options have a 10-year term and vests quarterly through December 31, 2025, subject to continued service through each such date

F2 · balance_after: Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of cash retainer fees of $69,000.

SEC source: 0001753926-25-001031 · form4.xml · derivative · entry 2

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,393

Underlying: Common Stock · 364 shares

Expires 2034-12-31

F3 · kind: Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 76,757 to 76,393 due to a clerical error.

F3 · shares: Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 76,757 to 76,393 due to a clerical error.

F4 · derivative.exercise_date: The option will vest one-fourth at the end of each calendar quarter following the grant date, subject to continued service through each such date.

F3 · derivative.underlying_shares: Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 76,757 to 76,393 due to a clerical error.

F3 · balance_after: Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 76,757 to 76,393 due to a clerical error.

SEC source: 0001753926-25-001027 · form4.xml · derivative · entry 2

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,822

Underlying: Common Stock · 237 shares

Expires 2034-12-31

F3 · kind: Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 50,059 to 49,822 due to a clerical error.

F3 · shares: Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 50,059 to 49,822 due to a clerical error.

F4 · derivative.exercise_date: The option will vest one-fourth at the end of each calendar quarter following the grant date, subject to continued service through each such date.

F3 · derivative.underlying_shares: Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 50,059 to 49,822 due to a clerical error.

F3 · balance_after: Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 50,059 to 49,822 due to a clerical error.

SEC source: 0001753926-24-001875 · primary_doc.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,695,861

F1 · kind: The reporting person purchased 3,968,253 shares of the Issuer,s common stock in a private sale transaction at a price of $1.26 per share, which was the lower of the closing price of the Issuer's common stock on the Nasdaq or the 5-day average closing price of the Issuer's common stock on the Nasdaq, each immediately prior to the closing date, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the common stock that occur after the date of the private sale transaction. The gross proceeds from this private sale transaction were $5,000,000.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.

SEC source: 0001753926-24-001643 · primary_doc.xml · nonDerivative · entry 3

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

F1 · kind: Individual purchased shares on the open market.

SEC source: 0001753926-24-001643 · primary_doc.xml · nonDerivative · entry 2

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,500

F1 · kind: Individual purchased shares on the open market.

SEC source: 0001753926-24-001643 · primary_doc.xml · nonDerivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,500

F1 · kind: Individual purchased shares on the open market.

SEC source: 0001753926-24-001335 · primary_doc.xml · nonDerivative · entry 2

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,500

F1 · kind: Individual purchased shares on the open market.

SEC source: 0001753926-24-001335 · primary_doc.xml · nonDerivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,500

F1 · kind: Individual purchased shares on the open market.

SEC source: 0001753926-25-002003 · form4.xml · nonDerivative · entry 1

Mendelsohn Aaron · CIK 0001625195 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,170

F1 · date: A Form 4 to disclose the gift of 20,000 shares made to a non-affiliated entity on 07/08/2024 was inadvertently not previously filed.

SEC source: 0001753926-24-001195 · ownership.xml · derivative · entry 1

Baker Wilford Dean · CIK 0001377879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,839

Underlying: Common Stock · 34,839 shares

Expires 2034-06-26

F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's non-employee director compensation policy.

F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date.

F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date.

SEC source: 0001753926-24-001197 · ownership.xml · derivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,839

Underlying: Common Stock · 34,839 shares

Expires 2034-06-26

F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's non-employee director compensation policy.

F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date.

F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date.

SEC source: 0001753926-24-001193 · ownership.xml · derivative · entry 1

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,839

Underlying: Common Stock · 34,839 shares

Expires 2034-06-26

F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's non-employee director compensation policy.

F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date.

F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date.

SEC source: 0001753926-24-001191 · ownership.xml · derivative · entry 1

Larson Alexandra L.P. · CIK 0001858534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,839

Underlying: Common Stock · 34,839 shares

Expires 2034-06-26

F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's non-employee director compensation policy.

F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date.

F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date.

SEC source: 0001753926-24-001189 · ownership.xml · derivative · entry 1

Mendelsohn Aaron · CIK 0001625195 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,839

Underlying: Common Stock · 34,839 shares

Expires 2034-06-26

F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's non-employee director compensation policy.

F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date.

F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date.

SEC source: 0001753926-24-000966 · ownership.xml · derivative · entry 2

Mendelsohn Adam · CIK 0001940008 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

SEC source: 0001753926-24-000966 · ownership.xml · derivative · entry 1

Mendelsohn Adam · CIK 0001940008 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001753926-24-000968 · ownership.xml · derivative · entry 2

Le Truc · CIK 0001940176 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

SEC source: 0001753926-24-000968 · ownership.xml · derivative · entry 1

Le Truc · CIK 0001940176 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001753926-24-000967 · ownership.xml · derivative · entry 2

Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

SEC source: 0001753926-24-000967 · ownership.xml · derivative · entry 1

Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001753926-24-000965 · ownership.xml · derivative · entry 2

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

SEC source: 0001753926-24-000965 · ownership.xml · derivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001753926-24-000964 · ownership.xml · derivative · entry 2

Makes Brigid · CIK 0001375927 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

SEC source: 0001753926-24-000964 · ownership.xml · derivative · entry 1

Makes Brigid · CIK 0001375927 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001753926-24-000644 · ownership.xml · derivative · entry 1

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,145

Underlying: Common Stock · 26,145 shares

Expires 2034-03-26

F2 · price: Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of pro-rated cash retainer fees of $37,500.

F1 · derivative.exercise_date: The stock options have a 10-year term and vests quarterly through December 31, 2024.

F2 · balance_after: Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of pro-rated cash retainer fees of $37,500.

SEC source: 0001753926-24-000622 · ownership.xml · derivative · entry 1

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,869

Underlying: Common Stock · 22,869 shares

Expires 2034-03-24

F1 · derivative.exercise_date: The stock options have a 10-year term and vest monthly equally over three years.